Clinical Laboratory & Biomarker Core
临床实验室
基本信息
- 批准号:10612986
- 负责人:
- 金额:$ 48.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-02 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAreaAwarenessBiologicalBiological AssayBiological MarkersBiological Specimen BanksBiological TestingCatalogingCertificationClinicClinicalClinical DataClinical ResearchCollaborationsConsultConsultationsDataData AnalysesDevelopmentEducational process of instructingEquipment and supply inventoriesFacultyGoalsGuidelinesHIVHIV InfectionsImmunologyInstitutionInternationalInternetInvestigationKnowledgeLaboratoriesMaintenanceMeasuresMentorsMethodsNatural HistoryOutcome StudyPathogenesisPerformancePharmacologyPractice ManagementPreventionPublicationsQuality ControlReadinessResearchResearch PersonnelResourcesSamplingScienceScientistService provisionServicesSpecimenStudentsTestingTissue BanksTrainingbiobankdata integritydata managementdesignimprovedinnovationmetabolomicsnext generationprogramsquality assurancerepositorysearchable databaseservice providersvirologyworking group
项目摘要
The overall goals of the JHUCFAR Laboratory core are to provide JHU HIV researchers, especially those
new to HIV, with: a) world‐class laboratory expertise to assist in the optimal design of clinical studies
where specialized laboratory assays are essential to measuring study outcomes, b) access to
appropriate, validated and, where applicable, certified laboratory assays, c) biomarker specimen
repository for the storage, cataloguing and testing of biological specimens, including access to the
clinical data associated with those specimens, and d) training to match the needs of investigators
ranging from understanding how to collaborate with laboratory investigators, incorporate laboratory
tests in a clinical study, judge assay quality and readiness for use to actual performance of the assays in
one’s own laboratory. The Core will establish mechanisms to enhance research in HIV prevention,
treatment, and pathogenesis carried out by both new and established investigators at JHU through
improved awareness of and access to the extensive laboratory resources within the institution and by
establishing connections outside Johns Hopkins when needed. To this end, the Core will directly provide
expert consultation and assay service focused in 4 major scientific areas—virology, immunology,
pharmacology, and metabolomics—as well as providing access to both data and biological specimen
repositories to advance science. Beyond these laboratories, the Core will establish best data
management practices – from clinic to lab to data analysis – and facilitate connections and
collaborations with a far broader array of core laboratories within JHU and in other CFARs nationally.
JHUCFAR 实验室核心的总体目标是为 JHU HIV 研究人员,特别是那些
HIV 新手,具有:a) 世界一流的实验室专业知识,可协助临床研究的最佳设计
当专门的实验室检测对于衡量研究结果至关重要时,b) 获得
适当的、经过验证的和(如适用)经认证的实验室测定,c) 生物标志物样本
用于存储、编目和测试生物样本的存储库,包括访问
与这些标本相关的临床数据,以及 d) 满足研究人员需求的培训
从了解如何与实验室研究人员合作、整合实验室
临床研究中的测试,判断测定质量和用于实际测定性能的准备情况
核心将建立加强艾滋病毒预防研究的机制,
约翰霍普金斯大学的新老研究人员通过以下方式进行了治疗和发病机制的研究:
提高对机构内广泛实验室资源的认识和获取,并通过
需要时在约翰霍普金斯大学外部建立联系,核心将直接提供。
专家咨询和检测服务专注于4个主要科学领域——病毒学、免疫学、
药理学和代谢组学,以及提供数据和生物样本的访问
除了这些实验室之外,核心还将建立最好的数据。
管理实践——从诊所到实验室再到数据分析——并促进联系和
与 JHU 和全国其他 CFAR 中更广泛的核心实验室进行合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Craig Walter Hendrix其他文献
Craig Walter Hendrix的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Craig Walter Hendrix', 18)}}的其他基金
Population Pharmacokinetic Modeling and Clinical Trial Simulation to optimize HIV Prevention in Pregnancy and Postpartum
群体药代动力学模型和临床试验模拟可优化妊娠期和产后的艾滋病毒预防
- 批准号:
10316144 - 财政年份:2021
- 资助金额:
$ 48.76万 - 项目类别:
Development of Rectal Enema As Microbicide (DREAM)
直肠灌肠剂作为杀菌剂的开发(DREAM)
- 批准号:
9088326 - 财政年份:2014
- 资助金额:
$ 48.76万 - 项目类别:
Exploratory Pharmcokinetics of UC781 & Tenofovir Vaginal Microbicide Gel V Film
UC781 的探索性药代动力学
- 批准号:
8660270 - 财政年份:2014
- 资助金额:
$ 48.76万 - 项目类别:
Clinical optimization of a tenofovir enema and adherence tracking
替诺福韦灌肠和依从性跟踪的临床优化
- 批准号:
8768695 - 财政年份:2014
- 资助金额:
$ 48.76万 - 项目类别:
The effect of Depo-Provera on HIV susceptibility, immune activation, and PrEP PK
Depo-Provera 对 HIV 易感性、免疫激活和 PrEP PK 的影响
- 批准号:
8588047 - 财政年份:2013
- 资助金额:
$ 48.76万 - 项目类别:
Exploratory Pharmcokinetics of UC781 & Tenofovir Vaginal Microbicide Gel V Film
UC781 的探索性药代动力学
- 批准号:
8471644 - 财政年份:2013
- 资助金额:
$ 48.76万 - 项目类别:
相似国自然基金
从CD4+、CD8+T细胞免疫活化分子及其上游调控因子表达探究健脾祛湿法治疗艾滋病免疫调节机制
- 批准号:81460716
- 批准年份:2014
- 资助金额:48.0 万元
- 项目类别:地区科学基金项目
HAART过程中HCV复制增强与肝细胞MAVS抗病毒通路的关系研究
- 批准号:81201286
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 48.76万 - 项目类别:
KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
- 批准号:
10763054 - 财政年份:2023
- 资助金额:
$ 48.76万 - 项目类别:
SUPPORT SERVICES FOR HIV AIDS CLINICAL TRIAL NETWORKS
HIV 艾滋病临床试验网络的支持服务
- 批准号:
10872942 - 财政年份:2023
- 资助金额:
$ 48.76万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心
- 批准号:
10595899 - 财政年份:2023
- 资助金额:
$ 48.76万 - 项目类别: